Treatment of human colon cancer cells with interferon-gamma (IFN-γ) downregulates level of S100A4 mRNA in a time- and dose-dependent manner without associating with any cytotoxicities [179]. The gene discussed is S100A4; the disease is malignant colon neoplasm.